R&D, Pharmacovigilance & Regulatory Affairs

R&D, Pharmacovilance & Regulatory Affairs

Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.

  • R&D, Pharmacovilance & Regulatory Affairs

    Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.
Title Location Date Sort descending Req ID
Reset
Senior Manager, CMC Regulatory Affairs, Global Rare Diseases
Senior Manager, CMC Regulatory Affairs, Global Rare Diseases Europe, IT Mar 11, 2026 6592
Europe, IT Mar 11, 2026 6592
Pharmazeut (all genders) im Praktikum für 2026 / 2027
Pharmazeut (all genders) im Praktikum für 2026 / 2027 Hamburg, DE Mar 7, 2026 351
Hamburg, DE Mar 7, 2026 351
INTERN - Patient Engagement
INTERN - Patient Engagement PARMA, IT Feb 27, 2026 5993
PARMA, IT Feb 27, 2026 5993
Sr. Manager, CMC Regulatory Affairs
Sr. Manager, CMC Regulatory Affairs United States, US Feb 20, 2026 6204
United States, US Feb 20, 2026 6204
Clinical Program Leader, Neonatology & Care
Clinical Program Leader, Neonatology & Care Europe, IT Feb 19, 2026 6955
Europe, IT Feb 19, 2026 6955
R&D Manufacturing & Technology Transfer Manager
R&D Manufacturing & Technology Transfer Manager Parma, IT Feb 18, 2026 6501
Parma, IT Feb 18, 2026 6501
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases Europe, IT Feb 16, 2026 6111
Europe, IT Feb 16, 2026 6111
Senior Director, Clinical Biometrics & Analytics
Senior Director, Clinical Biometrics & Analytics Parma, IT Feb 12, 2026 6387
Parma, IT Feb 12, 2026 6387